Many Pregnant Women Get Too Much Folic Acid, New Study Finds
One piece of nutritional advice unfailingly drummed into the heads of women who are pregnant or trying to become pregnant is: Take plenty of folic acid. In a new study of more than 1,000…
One piece of nutritional advice unfailingly drummed into the heads of women who are pregnant or trying to become pregnant is: Take plenty of folic acid. In a new study of more than 1,000…
Minerva Neurosciences saw its shares jump on Monday after the firm announced results from a trial related to an insomnia treatment.
Vacation is supposed to be the sort of downtime which is good to clear the mind and relieve tension. It apparently has physical health benefits as well, beyond whatever exercise the vacationer might do.…
A new large-scale study conducted by Korean researchers, the results of which were just published in the European Heart Journal, has established a significant link between the common cardiac arrhythmia called atrial fibrillation, or…
Ocular Therapeutix shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Dextenza to include the treatment of ocular inflammation…
Marijuana trends showing higher use after cannabis legalization in Canada.
Swiss researchers have established that tannins found in pomegranates are converted in the digestive system into a compound that appears to slow down mitochondrial aging — a natural process that weakens cells and causes…
Melinta Therapeutics shares nearly doubled early on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Baxdela (delafloxacin) for priority review.
Health care stocks still have plenty of upside in them. Agilent, Danaher, Thermo Fisher are all stocks to buy.
Analyst Yun Zhong looks at two treatments for Alzheimer Disease and other dementias that could beat the odds and be winners in treating these awful afflictions.
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus price target.
PhaseBio Pharmaceuticals shares jumped on Tuesday after the firm announced preliminary results from its mid-stage trial on subjects on dual antiplatelet therapy of ticagrelor and low-dose aspirin.
Baldness is something that many men fear as they age, and understandably so. But Aclaris Therapeutics may have found an answer to it in its most recent mid-stage clinical trial.
A blood pressure medication widely used in Europe and Japan might have potential to slow down the progress of Alzheimer’s disease, according to a new study appearing in Hypertension, a journal published by the…
Array BioPharma shares shot up on Monday after the firm announced that it would be acquired by Pfizer in an all cash transaction. The boards of directors of both companies have approved the merger…